Substituted phenylamino-pyrimidines

US7723347B2 · kind B2 · utility

Assignee

• Bayer Schering Pharma AG · DE

Inventors

• Hartmut Schirok · Wuppertal, DE
• Johannes-Peter Stasch · Wuppertal, DE
• Raimund Kast · Wuppertal, DE
• Klaus Münter · Mannheim, DE
• Marc Jean Gnoth · Mettmann, DE
• Santiago Figureoa Perez · Leverkusen, DE
• Michael Thutewohl · Buchs, CH
• Samir Bennabi · Wuppertal, DE
• Dieter Lang · Velbert, DE
• Joachim Mittendorf · Wuppertal, DE
• Martin Radtke · Erkrath, DE
• Heimo Ehmke · Hamburg, DE

Key dates

• Filing date: Apr 14, 2005
• Grant date: May 25, 2010
• Expiry date: Apr 27, 2026

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to substituted phenylaminopyrimidines, to a process for their preparation and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular cardiovascular disorders.